CN Patent

CN116322682A — 在治疗儿科患者的高脂血症和高胆固醇血症的方法中使用的洛美他派

Assigned to Amylin Pharmaceuticals LLC · Expires 2023-06-23 · 3y expired

What this patent protects

本文提供了用洛美他派或其药学上可接受的盐治疗儿科患者的高脂血症或高胆固醇血症的方法。

USPTO Abstract

本文提供了用洛美他派或其药学上可接受的盐治疗儿科患者的高脂血症或高胆固醇血症的方法。

Drugs covered by this patent

doxepin-hydrochloride (DOXEPIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN116322682A
Jurisdiction: CN
Classification: —
Expires: 2023-06-23
Drug substance claim: No
Drug product claim: No
Assignee: Amylin Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.